Fern plant-derived protoapigenone leads to DNA damage, apoptosis, and g2/m arrest in lung cancer cell line H1299

DNA and Cell Biology

Volumn 28, Issue 10, 2009, Pages 501-506

  Chiu, Chien Chih ^a   Chang, Hsueh Wei ^a   Chuang, Da Wei ^a   Chang, Fang Rong ^a   Chang, Yu Ching ^b   Cheng, Yu Shan ^a   Tsai, Ming Tz ^a   Chen, Wan Yu ^a   Lee, Su Shuo ^a   Wang, Chih Kuang ^a   Chen, Jeff Yi Fu ^a   Wang, Hui Min ^a   Chen, Chao Chieh ^a   Liu, Yin Chang ^c   Wu, Yang Chang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLAVONOID; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTOAPIGENONE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL KILLING; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSIMETRY; FERN; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE TEST; LUNG CANCER; MEDICINAL PLANT; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; COMET ASSAY; CYCLOHEXANONES; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FERNS; FLAVONES; FLOW CYTOMETRY; G2 PHASE; HUMANS; LUNG NEOPLASMS;

FILICOPHYTA; MACROTHELYPTERIS TORRESIANA;

EID: 70349441081     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0852     Document Type: Article

References (24)

1. Arts, I.C. (2008). A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr 138, 1561S-1566S.
2. Bayman, N.A., Sheikh, H., Kularatne, B., Lorigan, P., Blackhall, F., Thatcher, N., and Faivre-Finn, C. (2009). Radiotherapy for small-cell lung cancer-where are we heading? Lung Cancer 63, 307-314.
3. Branzei, D., and Foiani, M. (2008). Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 9, 297-308.
4. Chang, H.L., Su, J.H., Yeh, Y.T., Lee, Y.C., Chen, H.M., Wu, Y.C., and Yuan, S.S. (2008a). Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo. Cancer Lett 267, 85-95.
5. Chang, H.L., Wu, Y.C., Su, J.H., Yeh, Y.T., and Yuan, S.S. (2008b). Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogenactivated protein kinase and c-Jun NH2-terminal kinase 1=2. J Pharmacol Exp Ther 325, 841-849.
6. Chang, Y.C., Jan, K.Y., Cheng, C.A., Liao, C.B., and Liu, Y.C. (2008c). Direct involvement of the tumor suppressor p53 in nucleotide excision repair. DNA Repair (Amst) 7, 751-761.
7. Chang, Y.C., Liao, C.B., Hsieh, P.Y., Liou, M.L., and Liu, Y.C. (2008d). Expression of tumor suppressor p53 facilitates DNA repair but not UV-induced G2=M arrest or apoptosis in Chinese hamster ovary CHO-K1 cells. J Cell Biochem 103, 528-537.
8. Chien, C.M., Yang, S.H., Yang, C.C., Chang, L.S., and Lin, S.R. (2008). Cardiotoxin III induces c-jun N-terminal kinasedependent apoptosis in HL-60 human leukaemia cells. Cell Biochem Funct 26, 111-118.
9. Chiu, C.C., Li, C.H., Fuh, T.S., Chen, W.L., Huang, C.S., Chen, L.J., Ung, W.H., and Fang, K. (2005). The suppressed proliferation and premature senescence by ganciclovir in p53- mutated human non-small-lung cancer cells acquiring herpes simplex virus-thymidine kinase cDNA. Cancer Detect Prev 29, 286-293.
10. Collins, A.R., Oscoz, A.A., Brunborg, G., Gaivao, I., Giovannelli, L., Kruszewski, M., Smith, C.C., and Stetina, R. (2008). The comet assay: topical issues. Mutagenesis 23, 143-151.
11. Gallicchio, L., Boyd, K., Matanoski, G., Tao, X.G., Chen, L., Lam, T.K., Shiels, M., Hammond, E., Robinson, K.A., Caulfield, L.E., Herman, J.G., Guallar, E., and Alberg, A.J. (2008). Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 88, 372-383.
12. Gomes, A., Fernandes, E., Lima, J.L., Mira, L., and Corvo, M.L. (2008). Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem 15, 1586-1605.
13. Hooper, L., Kroon, P.A., Rimm, E.B., Cohn, J.S., Harvey, I., Le Cornu, K.A., Ryder, J.J., Hall, W.L., and Cassidy, A. (2008). Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 38-50.
14. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J Clin 58, 71-96.
15. Lin, A.S., Chang, F.R., Wu, C.C., Liaw, C.C., and Wu, Y.C. (2005). New cytotoxic flavonoids from Thelypteris torresiana. Planta Med 71, 867-870.
16. Lin, A.S., Nakagawa-Goto, K., Chang, F.R., Yu, D., Morris-Natschke, S.L., Wu, C.C., Chen, S.L., Wu, Y.C., and Lee, K.H. (2007). First total synthesis of protoapigenone and its analogues as potent cytotoxic agents. J Med Chem 50, 3921-3927.
17. Lin, C.N., Chen, H.L., and Yen, M.H. (2008). Flavonoids with DNA strand-scission activity from Rhus javanica var. roxburghiana. Fitoterapia 79, 32-36.
18. Renis, M., Calandra, L., Scifo, C., Tomasello, B., Cardile, V., Vanella, L., Bei, R., La Fauci, L., and Galvano, P. (2008). Response of cell cycle=stress-related protein expression and DNA damage upon treatment of CaCO2 cells with anthocyanins. Br J Nutr 100, 27-35.
19. Rossi, A., Maione, P., Palazzolo, G., Sacco, P.C., Ferrara, M.L., Falanga, M., and Gridelli, C. (2008). New targeted therapies and small-cell lung cancer. Clin Lung Cancer 9, 271-279.
20. Saloustros, E., and Georgoulias, V. (2008). Docetaxel in the treatment of advanced non-small-cell lung cancer. Expert Rev Anticancer Ther 8, 1207-1222.
21. Spencer, J.P. (2008). Flavonoids: modulators of brain function? Br J Nutr 99E Suppl 1, ES60-ES77.
22. Teillet, F., Boumendjel, A., Boutonnat, J., and Ronot, X. (2008). Flavonoids as RTK inhibitors and potential anticancer agents. Med Res Rev 28, 715-745.
23. Wasson, G.R., McKelvey-Martin, V.J., and Downes, C.S. (2008). The use of the comet assay in the study of human nutrition and cancer. Mutagenesis 23, 153-162.
24. Yamamoto, H., Sekine, I., Yamada, K., Nokihara, H., Yamamoto, N., Kunitoh, H., Ohe, Y., and Tamura, T. (2008). Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxel. Oncology 75, 169-174.